A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma

Vincent W. Keng; Augusto Villanueva; Derek Y. Chiang; Adam J. Dupuy; Barbara J. Ryan; Ilze Matise; Kevin A.T. Silverstein; Aaron L. Sarver; Timothy K. Starr; Keiko Akagi; Lino Tessarollo; Lara S. Collier; Scott Powers; Scott W. Lowe; Nancy A. Jenkins; Neal G. Copeland; Josep M. Llovet; David A. Largaespada

doi:10.1038/nbt.1526

Related publications

Article2015

P0224 : Nintedanib prevents the development of hepatocellular carcinoma in a mouse model of fibrosis

Victoria Tovar, A. Moeni, Sara Torrecilla, Mónica Higuera, Judit Peix, I.M. Quetglas, Leonardo Rodríguez‐Carunchio, Manel Solé, Josep M. Llovet

Journal of Hepatology

Article2021

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet, Florian Castet, Mathias Heikenwälder, Mala K. Maini, Vincenzo Mazzaferro, David J. Pinato, Eli Pikarsky, Andrew X. Zhu, Richard S. Finn

Nature Reviews Clinical Oncology

Article2003

Hepatocellular carcinoma: a clinical update.

Fernando Pons-Renedo, Josep M. Llovet

PubMed

Article2010

226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATION

María Reig, Alejandro Forner, Carlos Rodríguez de Lope, Jordi Rimola, Silvia Tremosini, C. Mestres, Carmen Ayuso, Josep M. Llovet, Jordi Bruix

Journal of Hepatology

Article2021

Hepatocellular carcinoma

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman‐Rossi, Richard S. Finn

Nature Reviews Disease Primers